Vogel Todd R, Smith Jamie B, Kruse Robin L
Division of Vascular Surgery, Department of Surgery, University of Missouri, School of Medicine, Columbia, Mo.
Department of Family and Community Medicine, University of Missouri, School of Medicine, Columbia, Mo.
J Vasc Surg. 2017 Oct;66(4):1123-1132. doi: 10.1016/j.jvs.2017.01.053. Epub 2017 Apr 19.
The effect of postoperative hyperglycemia in patients undergoing open and endovascular procedures on the lower extremities has not been fully characterized with regard to associated admission diagnoses, hospital complications, mortality, and 30-day readmission. This study evaluated the relationship of postoperative hyperglycemia on outcomes after lower extremity vascular procedures for peripheral artery disease.
Patients with peripheral artery disease admitted for elective lower extremity procedures between September 2008 and March 2014 were selected from the Cerner Health Facts (Cerner Corporation, Kansas City, Mo) database using International Classification of Diseases, Ninth Edition, Clinical Modification diagnosis and procedure codes. Using χ analysis, we evaluated the relationship of postoperative hyperglycemia (>180 mg/dL) with sociodemographic characteristics, acute and chronic diagnoses, infections, hospital length of stay (LOS), and 30-day readmission. An adjusted multivariable logistic model was used to examine the association of postoperative hyperglycemia with infection and LOS.
Of 3586 patients in the study, 2812 (78%) had optimal postoperative glucose control, and 774 (22%) had suboptimal glucose control (hyperglycemia). On average, patients with postoperative hyperglycemia experienced longer hospital stays (6.9 vs 5.1 days; P < .0001), higher Charlson Comorbidity Index scores (3.4 vs 2.5, P < .0001), higher rates of infection (23% vs 14%, P < .0001), more acute complications (ie, fluid and electrolyte disorders, acute renal failure, postoperative respiratory complications), and chronic problems (ie, anemia, chronic heart disease, chronic kidney disease, and diabetes) than patients with optimal glucose control. Overall 30-day readmission was 10.9% and was similar between the groups (10.9% for both; P = .93). Major amputations did not differ between groups (P = .21). After adjusting for other risk factors using multivariable logistic regression, patients with hyperglycemia have 1.3-times the odds to have an infectious complication compared with those with optimal glucose control (odds ratio [OR], 1.34; 95% confidence interval [CI], 1.06-1.69) and 1.7-times the odds to have a hospital LOS >10 days (OR, 1.69; 95% CI, 1.32-2.15). As well, patients with postoperative hyperglycemia have 8.4-times the odds of dying in the hospital (OR, 8.40; 95% CI, 3.95-17.9).
One in five patients undergoing vascular procedures had postoperative hyperglycemia. Postoperative hyperglycemia was associated with adverse events after lower extremity vascular procedures in patients with and without diabetes, including infection, increased hospital utilization, and mortality. No difference was found with respect to hospital readmission. Postprocedure glucose management may represent an important quality marker for improving outcomes after lower extremity vascular procedures.
关于接受开放性和血管腔内手术治疗下肢疾病的患者,术后高血糖在相关入院诊断、医院并发症、死亡率及30天再入院方面的影响尚未得到充分描述。本研究评估了外周动脉疾病患者下肢血管手术后术后高血糖与预后的关系。
从Cerner Health Facts(Cerner公司,密苏里州堪萨斯城)数据库中,使用国际疾病分类第九版临床修订本的诊断和手术编码,选取2008年9月至2014年3月因择期下肢手术入院的外周动脉疾病患者。采用χ分析,我们评估了术后高血糖(>180mg/dL)与社会人口统计学特征、急慢性诊断、感染、住院时间(LOS)及30天再入院的关系。使用校正后的多变量逻辑模型来检验术后高血糖与感染及住院时间的关联。
研究中的3586例患者中,2812例(78%)术后血糖控制良好,774例(22%)血糖控制欠佳(高血糖)。平均而言,术后高血糖患者的住院时间更长(6.9天对5.1天;P<.0001),Charlson合并症指数得分更高(3.4对2.5,P<.0001),感染率更高(23%对14%,P<.0001),急性并发症(即液体和电解质紊乱、急性肾衰竭、术后呼吸并发症)及慢性问题(即贫血、慢性心脏病、慢性肾病和糖尿病)比血糖控制良好的患者更多。总体30天再入院率为10.9%,两组相似(均为10.9%;P=.93)。两组间大截肢率无差异(P=.21)。使用多变量逻辑回归校正其他危险因素后,高血糖患者发生感染并发症的几率是血糖控制良好患者的1.3倍(优势比[OR],1.34;95%置信区间[CI],1.06 - 1.69),住院时间>10天的几率是其1.7倍(OR,1.69;95%CI,1.32 - 2.15)。同样,术后高血糖患者在医院死亡的几率是其8.4倍(OR,8.40;95%CI,3.95 - 17.9)。
接受血管手术的患者中有五分之一术后出现高血糖。术后高血糖与糖尿病和非糖尿病患者下肢血管手术后的不良事件相关,包括感染、医院资源利用增加及死亡率。在医院再入院方面未发现差异。术后血糖管理可能是改善下肢血管手术后预后的一个重要质量指标。